These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33291630)

  • 1. Technologies for Pharmacogenomics: A Review.
    van der Lee M; Kriek M; Guchelaar HJ; Swen JJ
    Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33291630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
    Ji Y; Si Y; McMillin GA; Lyon E
    Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrogating Pharmacogenetics Using Next-Generation Sequencing.
    Ji Y; Shaaban S
    J Appl Lab Med; 2024 Jan; 9(1):50-60. PubMed ID: 38167765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
    Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
    J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a Large Custom-Designed Pharmacogenomics Panel on an Array Genotyping Platform.
    Tang NY; Pei X; George D; House L; Danahey K; Lipschultz E; Ratain MJ; O'Donnell PH; Yeo KJ; van Wijk XMR
    J Appl Lab Med; 2021 Nov; 6(6):1505-1516. PubMed ID: 34263311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Next-Generation Sequencing in Pharmacogenomics.
    Enko D; Michaelis S; Schneider C; Schaflinger E; Baranyi A; Schnedl WJ; Muller DJ
    Clin Lab; 2023 Aug; 69(8):. PubMed ID: 37560847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards population-specific pharmacogenomics in the era of next-generation sequencing.
    Ji X; Ning B; Liu J; Roberts R; Lesko L; Tong W; Liu Z; Shi T
    Drug Discov Today; 2021 Aug; 26(8):1776-1783. PubMed ID: 33892143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotype determination of the Bombyx mori nucleopolyhedrovirus by Nanopore sequencing and linkage of single nucleotide variants.
    Wennmann JT; Lim FS; Senger S; Gani M; Jehle JA; Keilwagen J
    J Gen Virol; 2024 May; 105(5):. PubMed ID: 38767624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
    Lauschke VM; Ingelman-Sundberg M
    Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering next-generation pharmacogenomics: an information technology perspective.
    Potamias G; Lakiotaki K; Katsila T; Lee MT; Topouzis S; Cooper DN; Patrinos GP
    Open Biol; 2014 Jul; 4(7):. PubMed ID: 25030607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing in pharmacogenomics - fit for clinical decision support?
    Zhou Y; Lauschke VM
    Expert Rev Clin Pharmacol; 2024 Mar; 17(3):213-223. PubMed ID: 38247431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining Cost-Optimal Next-Generation Sequencing Panels for Rare Disease and Pharmacogenomics Testing.
    Katragadda S; Hall TO; Bettadapura R; Dalton JC; Ganapathy A; Ghana P; Hariharan R; Janakiraman A; Kotha KBVSSP; Manjunath A; Mannan AU; Ms N; Saraf S; Tzeng KTH; Veeramachaneni V
    Clin Chem; 2021 Aug; 67(8):1122-1132. PubMed ID: 34120169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
    Russell LE; Schwarz UI
    Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Next Generation Sequencing in Laboratory Medicine.
    Zhong Y; Xu F; Wu J; Schubert J; Li MM
    Ann Lab Med; 2021 Jan; 41(1):25-43. PubMed ID: 32829577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
    Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics Clinical Annotation Tool (PharmCAT).
    Sangkuhl K; Whirl-Carrillo M; Whaley RM; Woon M; Lavertu A; Altman RB; Carter L; Verma A; Ritchie MD; Klein TE
    Clin Pharmacol Ther; 2020 Jan; 107(1):203-210. PubMed ID: 31306493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Added Value of Clinical Sequencing: WGS-Based Profiling of Pharmacogenes.
    Caspar SM; Schneider T; Meienberg J; Matyas G
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From gene to dose: Long-read sequencing and *-allele tools to refine phenotype predictions of
    Graansma LJ; Zhai Q; Busscher L; Menafra R; van den Berg RR; Kloet SL; van der Lee M
    Front Pharmacol; 2023; 14():1076574. PubMed ID: 36937863
    [No Abstract]   [Full Text] [Related]  

  • 19. An efficient genotyper and star-allele caller for pharmacogenomics.
    Hari A; Zhou Q; Gonzaludo N; Harting J; Scott SA; Qin X; Scherer S; Sahinalp SC; Numanagić I
    Genome Res; 2023 Jan; 33(1):61-70. PubMed ID: 36657977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct Comparative Analysis of a Pharmacogenomics Panel with PacBio Hifi
    Barthélémy D; Belmonte E; Pilla LD; Bardel C; Duport E; Gautier V; Payen L
    J Pers Med; 2023 Nov; 13(12):. PubMed ID: 38138882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.